Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
5 th Meeting of NIC in Western Pacific and South East Asia Region PowerPoint Presentation
Download Presentation
5 th Meeting of NIC in Western Pacific and South East Asia Region

5 th Meeting of NIC in Western Pacific and South East Asia Region

159 Views Download Presentation
Download Presentation

5 th Meeting of NIC in Western Pacific and South East Asia Region

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. National Influenza Centres in SEA RegionDr Rajesh Bhatia / Dr Oommen JohnWHO Regional Office for South-East AsiaNew Delhi 5th Meeting of NIC in Western Pacific and South East Asia Region

  2. SEAR Timor Leste

  3. Seasonal Influenza • True burden in SEA Region still not fully understood • Disease burden studies • Thailand • Influenza occurs year-round • Follows a bimodal seasonal pattern with substantial variability. • Young children & elderly most affected • In-hospital deaths are more common than previously appreciated • Myanmar • Influenza exhibits seasonality, coincides with the rainy season June to Aug • India • Seasonality varies geographically

  4. Influenza Seasonality Pune (west) Delhi (north) Kolkota (east) Chennai (south)

  5. Location of NICs and H5 Reference Lab in SEAR Timor Leste

  6. NIC in SEAR *Bhutan, Maldives, and Timor Leste do not have a NIC at present but can perform PCR

  7. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO from SEA Region as on 01 June 2011

  8. NIHRD NIC SubNIC BLK Sby SubNIC Micro UI SubNIC Micro UNISU SubNIC BLK Bandung SubNIC BLK Palembang SubNIC Micro UNHAS SubNIC Micro UDAYANA SubNIC Micro UNDIP • LOCAL LABORATORY : • BTKL • Hospital Laboratory • District Laboratory National networks: Indonesia

  9. National network in India

  10. Location of 13 regional Medical Science Center National network in Thailand

  11. Regional strategy: 2008

  12. Activities in 2009-10 • Regional workshop on diagnosis of H1N1 • Regional workshop on monitoring resistance in influenza viruses • Regional Workshop on Biosafety and Biosecurity in labs : • Study visits to NIC staff within Region • Reagents procurement • Funding from various international partners

  13. Challenges • Capacity to diagnose all H types • Limited access to diagnostic services • No NIC in three countries • Coordination with animal health sector • Revision of NIPPP (post pandemic) • Data management and information sharing • Indigenous reagents production

  14. Future plans • NIC in all Member countries • Hand holding by established NIC for new and upcoming NICs • Revision of NIPPP • Collaboration with animal health sector • Expanding immunization and surveillance • Data sharing

  15. Experience from H1N1 2009 Pandemic • Expertise and Capacity within Region • Opportunity for strengthening regional and national preparedness and response capacity • Regional tools for assessment of response to pandemic H1N1( 2009) • Sharing of country experiences, lessons learned and best practices

  16. SEAR VPD Laboratory Network, 2010 (Polio, Measles/Rubella, JE/AES, Rota, IBD) Global specialized lab (Polio) Reference labs National labs

  17. Objectives • Strengthen the preparedness and capacity of SEAR member countries to respond to influenza with pandemic potential • Strengthen and integrate the capacity to carry out surveillance and response to seasonal and pandemic influenza • Strengthen laboratory infrastructure and build laboratory and epidemiology capacity to accurately and promptly diagnose seasonal influenza and influenza with pandemic potential.

  18. Implementation • Provide on going support to member countries in SEAR to review and modify their NIPRP • Assist member countries in SEAR to review regulations and policy related to use of Influenza vaccine • Build collaborative partnerships for research and production of influenza vaccine

  19. Implementation • Implementation of the Global Influenza Surveillance guidelines at regional level • Define minimum data sets needed for surveillance • Monitoring and evaluation support

  20. Build laboratory and epidemiology capacity • annual regional meeting of NICs to review progress • provide updates on new issues related to early detection of influenza and novel influenza strains • monitoring of anti-viral resistance • support for on-site laboratory trainings

  21. Collaborative Venture - National Influenza Centres • The Disease Surveillance and Epidemiology (DSE) unit of the Communicable Disease Surveillance (CDS) Department and • Immunization Vaccine and Development (IVD) unit of Family Health and Research (FHR) Department • Supported by CDC, Atlanta

  22. Thank You